Xilio Therapeutics, Inc. ($XLO)
Shannon James Samuel โ Director
Shares
5,000
Price
$8.79
Total Value
$43,950.00
P&L
-6.3% ($2,775.00)
Nearby Earnings
Mar 17, 2026
EPS:Est: -0.98
Revenue:Est: $10.90M
Mar 23, 2026 ๐
EPS:0.54 (est: -0.98)-155.4%
Revenue:$13.69M (est: $10.90M)+25.6%
Mar 24, 2026
EPS:Est: -0.98
Revenue:Est: $10.90M
Transaction Details
| Insider | Shannon James Samuel |
|---|---|
| Title | Director |
| Transaction Date | Mar 26, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 30, 2026 |
| Shares Purchased | 5,000 |
| Price per Share | $8.79 |
| Total Value | $43,950.00 |
| Shares Owned After | 10,000 |
| Derivative | No |
| Accession Number | 0001193125-26-131745 |
| Document | View SEC Filing |